Plain-English translation of NCT05411523 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying a medical device called a 10-kHz spinal cord stimulator—a small implant that sends mild electrical pulses to help reduce nerve pain. The study is looking at whether this device can help people who developed painful nerve damage from chemotherapy drugs, especially in their legs and feet. Researchers want to measure how much pain relief people get and how the treatment affects their sleep, mood, and overall quality of life.
Nerve pain after chemotherapy can be severe and difficult to treat with medications alone, leaving many patients still struggling with pain and reduced quality of life. This trial exists to see whether this stimulation device is an effective option for people whose pain hasn't improved with standard pain medications.
You likely qualify if…
You likely don't qualify if…
If you are already receiving spinal cord stimulation therapy, you would complete surveys about your pain, nerve function, sleep, and overall quality of life at four timepoints: when you start (baseline) and then at 3, 6, and 12 months afterward. Each survey takes about 30 minutes. This is an observational study, meaning researchers are tracking how the device you already have works for you—you are not being assigned to a new treatment.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States